Inari Medical Statistics
Total Valuation
Inari Medical has a market cap or net worth of $2.90 billion. The enterprise value is $2.82 billion.
Market Cap | 2.90B |
Enterprise Value | 2.82B |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
Earnings Date | Jul 31, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Inari Medical has 58.14 million shares outstanding. The number of shares has increased by 5.81% in one year.
Shares Outstanding | 58.14M |
Shares Change (YoY) | +5.81% |
Shares Change (QoQ) | +12.29% |
Owned by Insiders (%) | 9.34% |
Owned by Institutions (%) | 102.52% |
Float | 49.79M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.56 |
Forward PS | 4.56 |
PB Ratio | 6.47 |
P/FCF Ratio | 156.46 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1,437.64, with an EV/FCF ratio of 152.66.
EV / Earnings | n/a |
EV / Sales | 5.43 |
EV / EBITDA | 1,437.64 |
EV / EBIT | n/a |
EV / FCF | 152.66 |
Financial Position
The company has a current ratio of 2.71, with a Debt / Equity ratio of 0.07.
Current Ratio | 2.71 |
Quick Ratio | 2.10 |
Debt / Equity | 0.07 |
Debt / EBITDA | 16.03 |
Debt / FCF | 1.70 |
Interest Coverage | -44.50 |
Financial Efficiency
Return on equity (ROE) is -5.20% and return on invested capital (ROIC) is -4.09%.
Return on Equity (ROE) | -5.20% |
Return on Assets (ROA) | -3.90% |
Return on Capital (ROIC) | -4.09% |
Revenue Per Employee | $400,507 |
Profits Per Employee | -$18,169 |
Employee Count | 1,300 |
Asset Turnover | 0.86 |
Inventory Turnover | 1.58 |
Taxes
In the past 12 months, Inari Medical has paid $12.97 million in taxes.
Income Tax | 12.97M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -12.15% in the last 52 weeks. The beta is 1.02, so Inari Medical's price volatility has been similar to the market average.
Beta (5Y) | 1.02 |
52-Week Price Change | -12.15% |
50-Day Moving Average | 45.31 |
200-Day Moving Average | 53.34 |
Relative Strength Index (RSI) | 61.86 |
Average Volume (20 Days) | 699,271 |
Short Selling Information
The latest short interest is 4.74 million, so 8.15% of the outstanding shares have been sold short.
Short Interest | 4.74M |
Short Previous Month | 4.48M |
Short % of Shares Out | 8.15% |
Short % of Float | 9.52% |
Short Ratio (days to cover) | 5.88 |
Income Statement
In the last 12 months, Inari Medical had revenue of $520.66 million and -$23.62 million in losses. Loss per share was -$0.41.
Revenue | 520.66M |
Gross Profit | 456.44M |
Operating Income | -19.57M |
Pretax Income | -10.65M |
Net Income | -23.62M |
EBITDA | 1.97M |
EBIT | -10.41M |
Loss Per Share | -$0.41 |
Balance Sheet
The company has $101.80 million in cash and $31.49 million in debt, giving a net cash position of $70.31 million or $1.21 per share.
Cash & Cash Equivalents | 101.80M |
Total Debt | 31.49M |
Net Cash | 70.31M |
Net Cash Per Share | $1.21 |
Equity (Book Value) | 447.23M |
Book Value Per Share | 7.69 |
Working Capital | 147.28M |
Cash Flow
In the last 12 months, operating cash flow was $25.65 million and capital expenditures -$7.15 million, giving a free cash flow of $18.51 million.
Operating Cash Flow | 25.65M |
Capital Expenditures | -7.15M |
Free Cash Flow | 18.51M |
FCF Per Share | $0.32 |
Margins
Gross margin is 87.67%, with operating and profit margins of -3.76% and -4.54%.
Gross Margin | 87.67% |
Operating Margin | -3.76% |
Pretax Margin | -2.04% |
Profit Margin | -4.54% |
EBITDA Margin | 0.38% |
EBIT Margin | -2.00% |
FCF Margin | 3.55% |
Dividends & Yields
Inari Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -5.81% |
Shareholder Yield | -5.81% |
Earnings Yield | -0.82% |
FCF Yield | 0.64% |
Analyst Forecast
The average price target for Inari Medical is $65.71, which is 31.95% higher than the current price. The consensus rating is "Buy".
Price Target | $65.71 |
Price Target Difference | 31.95% |
Analyst Consensus | Buy |
Analyst Count | 7 |
Revenue Growth Forecast (5Y) | 19.48% |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Inari Medical has an Altman Z-Score of 8.95 and a Piotroski F-Score of 4.
Altman Z-Score | 8.95 |
Piotroski F-Score | 4 |